Satbir Thakur

Satbir Thakur is an experienced professional in the field of oncology and immuno-oncology, currently serving as an Assessment Officer at Health Canada since September 2021, where responsibilities include reviewing clinical and non-clinical data for oncology drug safety and efficacy. Prior to this role, Satbir worked as an Associate Research Scientist at the Arnie Charbonneau Cancer Institute, focusing on the development of neoantigen peptide and dendritic cell-based vaccines for childhood leukemia, and analyzing immune-modulatory drugs for various cancers and COVID-19. Experience also includes clinical research at Alberta Health Services, where notable work involved developing assays for prognostic significance in lung cancer and a semi-automated Ki67 assay for breast cancer differentiation. Satbir's academic background includes a PhD in Biochemistry and Molecular Biology from the University of Calgary, an MSc in Biotechnology from Punjabi University, and a BSc in Biotechnology from Guru Nanak Dev University.